GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Green Fresh Biotechnology Co 1084.HK · HKD

Materials · HKEX · 🇭🇰 Hong Kong

Compare

0.63

-0.79%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Green Fresh Biotechnology Co

Its shares trade on HKEX under the ticker 1084.HK. It has been listed since 17 October 2019. In the fiscal year to 31 December 2025, it reported revenue of CN¥904.3m and net income of CN¥6.6m. At that date it held total assets of CN¥1.63bn and shareholders' equity of CN¥839.1m.

Green Future Food Hydrocolloid Marine Science Co., Ltd. is an investment holding company, which engages in the production and sale of food manufacturing hydrocolloid products. The company employs 1,257 full-time employees The company went IPO on 2019-10-17. The firm primarily operates its business through five segments. The Manufacturing and Sales of Agar-agar segment is mainly engaged in the manufacture and sale of agar products which used in jelly. The Manufacturing and Sales of Carrageenan segment is mainly engaged in the manufacture and sales of carrageenan products used in confectionery and snacks. The Manufacturing and Sales of Konjac Product segment is mainly engaged in the manufacturing and sales of konjac products. The Manufacturing and Sales of Blended Product segment is mainly engaged in the manufacture and sales of compound products used in meat products. The Other segment is mainly engaged in the sale of milk powder.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Materials
Industry
Chemicals
Listed since
17 Oct 2019
Employees
1,257

Leadership

Pay as last reported

  • Mr. Kam Chung ChanExecutive Chairman of the Board, Chief Executive OfficerHK$1.0m
  • Mr. Shui Yip ChanExecutive Vice Chairman of the Board, Vice PresidentHK$885,000
  • Mr. Dongxu GuoExecutive Vice Chairman of the Board, Vice PresidentHK$878,000
  • Ms. Yi ChenExecutive Director, since 2024
  • Mr. Xiaoying SheExecutive DirectorHK$189,000
  • Mr. Chi Man SoCompany Secretary
  • Mr. Kwai Ching HoNon-Executive Independent DirectorHK$180,000
  • Mr. Guohua HuNon-Executive Independent DirectorHK$180,000
  • Mr. Man Kung NgNon-Executive Independent DirectorHK$180,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Green Fresh Biotechnology employs 1,257 skilled employees in Materials sector.
  • Green Fresh Biotechnology's Agar-agar segment produces jelly products for food manufacturing.
  • Green Fresh Biotechnology's Carrageenan segment supplies confectionery and snacks with carrageenan products.

Weaknesses

  • Green Fresh Biotechnology's Konjac Product segment focuses on limited market applications.
  • Green Fresh Biotechnology's Blended Product segment serves meat industry with specific needs.
  • Green Fresh Biotechnology's Other segment sells milk powder with low growth potential.

Opportunities

  • Green Fresh Biotechnology can expand its Agar-agar segment in the HK market.
  • Green Fresh Biotechnology can leverage its Carrageenan segment for global confectionery demand.
  • Green Fresh Biotechnology can grow its Konjac Product segment in health-conscious consumer markets.

Threats

  • Green Fresh Biotechnology faces competition from other Chemicals companies in HK.
  • Green Fresh Biotechnology's Blended Product segment may face raw material cost increases.
  • Green Fresh Biotechnology's milk powder sales in Other segment are vulnerable to market fluctuations.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.